Skip to main content
Clinical Trials/NCT01580098
NCT01580098CompletedNot Applicable

Regions of Europe Working Together for Health (Renewing Health)

Landeskrankenanstalten-Betriebsgesellschaft6 sites in 1 country193 target enrollmentStarted: February 1, 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
193
Locations
6
Primary Endpoint
Health Related Quality of Life as Measured by the Short Form 36 Version 2 Questionnaire

Study Overview

Brief Summary

Evaluation whether the introduction of large-scale personalized and technology supported telemonitoring and health coaching interventions produces benefits in terms of health related quality of life, health status and empowerment of patients with type 2 diabetes mellitus. In addition, the trials evaluate the economical and organizational impact of the new services and examine their acceptability by patients and health professionals.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • T2DM diagnosed > 3 months prior to the enrollment
  • HbA1c >= 6,5 %
  • Capability of filling questionnaires by their own language
  • Being able to use the devices provided
  • Being cognitively able to participate

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Health Related Quality of Life as Measured by the Short Form 36 Version 2 Questionnaire

Time Frame: 12 months

The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. The SF-36 is a measure of health status. Mearurement at the beginning and after 12 months, Scales from 0 to 100, higher values represent a better outcome; Data are mean scores (SD); differences between groups after 12 month were compared by using Mann-Whitney-U-tests.

HbA1c

Time Frame: 12 months

HbA1c was taken at the beginning of the study and after 12 months.

Secondary Outcomes

  • Blood Pressure(12 months)
  • Blood Lipids(12 months)
  • Body Weight(12 months)
  • Medication Changes(12 months)
  • Presence of Diabetic Complications(12 months)
  • Number of Hospitalisations(12 months)

Investigators

Sponsor
Landeskrankenanstalten-Betriebsgesellschaft
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (6)

Loading locations...

Similar Trials